As of September 2024, Paradigm Biopharmaceuticals has a market cap of $45.71M. This makes Paradigm Biopharmaceuticals the world's 24688th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $70.03M | -15.29% |
2023 | $82.67M | -69.75% |
2022 | $273.29M | -25.46% |
2021 | $366.66M | -26.08% |
2020 | $496.01M | -12.97% |
2019 | $569.93M | 185.73% |
2018 | $199.46M | 275.00% |
2017 | $53.19M | -28.21% |
2016 | $74.09M | 18.18% |
2015 | $62.69M | - |